Literature DB >> 19446763

Modeling and prediction of cocrystal phase diagrams.

Abigail Ainouz1, Jean-René Authelin, Pascal Billot, Harvey Lieberman.   

Abstract

In this paper, a new approach to model cocrystal phase diagrams is presented. Starting from an initial set of data, the phase diagram is obtained from discontinuous isoperibolic thermal analysis (DITA) and basic thermodynamic data (enthalpies and solubilities). The solubility product constant may then be determined. Since this constant is solvent independent, extrapolation to other solvents is possible. Application of this technique to an active pharmaceutical ingredient and glutaric acid demonstrates good agreement between calculated and experimental data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446763     DOI: 10.1016/j.ijpharm.2009.03.016

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Thermodynamic and kinetic investigation on the crucial factors affecting adefovir dipivoxil-saccharin cocrystallization.

Authors:  Kun Ma; Ying Zhang; Hongliang Kan; Linfeng Cheng; Ling Luo; Qing Su; Jing Gao; Yuan Gao; Jianjun Zhang
Journal:  Pharm Res       Date:  2014-02-13       Impact factor: 4.200

2.  A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.

Authors:  Chao Hong; Yan Xie; Yashu Yao; Guowen Li; Xiurong Yuan; Hongyi Shen
Journal:  Pharm Res       Date:  2014-06-18       Impact factor: 4.200

3.  Simultaneous formation and micronization of pharmaceutical cocrystals by rapid expansion of supercritical solutions (RESS).

Authors:  Katrin C Müllers; Maria Paisana; Martin A Wahl
Journal:  Pharm Res       Date:  2014-09-12       Impact factor: 4.200

4.  Application of twin screw extrusion in the manufacture of cocrystals, part I: four case studies.

Authors:  Dominick Daurio; Cesar Medina; Robert Saw; Karthik Nagapudi; Fernando Alvarez-Núñez
Journal:  Pharmaceutics       Date:  2011-08-31       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.